Citigroup Maintains Neutral on Insulet, Raises Price Target to $170
Benzinga Newsdesk 10 hours ago
Analyst RatingsNewsPrice Target
Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $150 to $170.
Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $150 to $170.